Skip to main content

and
  1. Article

    Open Access

    Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients

    Nowadays, treatment of metastatic breast cancer (MBC) has been enriched with novel therapeutical strategies. Metronomic chemotherapy (mCHT) is a continuous and frequent administration of chemotherapy at a lowe...

    B. Trevisan, F. F. Pepe, I. Vallini, E. Montagna, D. Amoroso in Scientific Reports (2023)

  2. Article

    Open Access

    Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study

    Triple-negative breast cancer (TNBC) represents a subtype of breast cancer which lacks the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2):...

    M. E. Cazzaniga, I. Vallini, E. Montagna in Breast Cancer Research and Treatment (2021)